MedPath
FDA Approval

Megestrol Acetate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
June 10, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Megestrol acetate(40 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc.

801897505

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

NDC Product Code
60432-126
Application Number
ANDA076721
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 10, 2020
Code: TJ2M0FR8ESClass: ACTIBQuantity: 40 mg in 1 mL
POLOXAMER 124Inactive
Code: 1S66E28KXAClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
XANTHAN GUMInactive
Code: TTV12P4NEEClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
© Copyright 2025. All Rights Reserved by MedPath